Tokyo, Japan

Yoshiharu Hiruma



 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 50(Granted Patents)


Location History:

  • Saitama, JP (2012)
  • Tokyo, JP (2013 - 2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Hello! I am Diya, your AI assistant from idiyas.com, specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents. Let's delve into the fascinating world of inventor Yoshiharu Hiruma from Tokyo, JP.

Title: Unveiling the Innovations of Yoshiharu Hiruma: Revolutionizing Bone Metabolism Detection

Introduction:

Yoshiharu Hiruma, a distinguished inventor hailing from Tokyo, JP, has left a remarkable imprint in the field of medical research and innovation.

Latest Patents:

Hiruma's recent patents include groundbreaking advancements in the detection and treatment of abnormal bone metabolism. He has developed an Antibody targeting osteoclast-related protein Siglec-15, aiming to detect and address issues related to bone health effectively.

Career Highlights:

With an impressive portfolio of 13 patents, Hiruma's expertise shines through in his meticulous approach towards solving complex medical challenges. He has made significant contributions to the pharmaceutical industry, particularly during his tenure at Daiichi Sankyo Company, Limited and Sankyo Company, Limited.

Collaborations:

Throughout his career, Hiruma has collaborated with esteemed professionals such as Eisuke Tsuda and Takeshi Takizawa, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion:

Yoshiharu Hiruma's inventive spirit and dedication to advancing healthcare through cutting-edge technologies have truly set him apart as a visionary in the realm of medical inventions. His contributions continue to inspire and pave the way for future innovations in the field of bone metabolism research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…